Tompkins Financial Corp Novartis Ag Transaction History
Tompkins Financial Corp
- $1.06 Billion
- Q4 2024
A detailed history of Tompkins Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Tompkins Financial Corp holds 2,910 shares of NVS stock, worth $310,933. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,910
Previous 2,910
-0.0%
Holding current value
$310,933
Previous $334,000
15.27%
% of portfolio
0.03%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding NVS
# of Institutions
1,443Shares Held
133MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$865 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$746 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$616 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...